The recent guidelines for AF diagnosis and treatment have shown that serum N-terminal-pro hormone brain natriuretic peptide (NT-proBNP) and left atrial diameters (LADs) are more powerful biomarkers than other clinical variables [1]. Here, NPPB is linked to atrial fibrillation.